The global outbreak of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a significant public health crisis, impacting communities and economies worldwide. The urgent need for an effective preventive measure has spurred the rapid development of COVID-19 vaccine candidates. Clinical trials play a pivotal role in assessing the safety, efficacy, and potential impact of these vaccines on reducing the spread of the virus.